Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Altimmune (ALT) Times Interest Earned: 2010-2025

Historic Times Interest Earned for Altimmune (ALT) over the last 16 years, with Sep 2025 value amounting to -$42.14.

  • Altimmune's Times Interest Earned rose 98.98% to -$42.14 in Q3 2025 from the same period last year, while for Sep 2025 it was -$118.87, marking a year-over-year increase of 98.94%. This contributed to the annual value of -$11,464 for FY2024, which is 318.25% down from last year.
  • According to the latest figures from Q3 2025, Altimmune's Times Interest Earned is -$42.14, which was up 51.47% from -$86.83 recorded in Q2 2025.
  • Altimmune's Times Interest Earned's 5-year high stood at $386.85 during Q4 2021, with a 5-year trough of -$26,794 in Q1 2024.
  • Over the past 3 years, Altimmune's median Times Interest Earned value was -$10,880 (recorded in 2023), while the average stood at -$12,904.
  • Its Times Interest Earned has fluctuated over the past 5 years, first soared by 107.03% in 2021, then slumped by 13,421.66% in 2023.
  • Altimmune's Times Interest Earned (Quarterly) stood at $386.85 in 2021, then tumbled by 67.38% to $126.20 in 2022, then plummeted by 13,421.66% to -$16,812 in 2023, then crashed by 47.91% to -$24,866 in 2024, then skyrocketed by 98.98% to -$42.14 in 2025.
  • Its last three reported values are -$42.14 in Q3 2025, -$86.83 for Q2 2025, and -$21,815 during Q1 2025.